Business Intelligence on Biologic and Small Molecule Drugs
Figure 3 – Statistical analysis of OIDD inputs over the life of the program
Figure 3. Statistical analysis of OIDD inputs over the life of the program demonstrates that on average 500 new compounds are registered each month, resulting in a steady increase in the OIDD compound collection over time. Since 2009 almost 2 million additional datapoints have been generated and leveraged to support the full complement of Lilly's scientific research efforts.